These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16793167)

  • 1. The emerging role of bile acids as integrators of intermediary metabolism.
    Groen AK
    J Hepatol; 2006 Aug; 45(2):337-8. PubMed ID: 16793167
    [No Abstract]   [Full Text] [Related]  

  • 2. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
    Tiwari A; Maiti P
    Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn errors of bile acid metabolism.
    Heubi JE; Setchell KD; Bove KE
    Semin Liver Dis; 2007 Aug; 27(3):282-94. PubMed ID: 17682975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Welcoming Foxa2 in the bile acid entourage.
    Moschetta A
    Cell Metab; 2008 Oct; 8(4):276-8. PubMed ID: 18840356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.
    Hofmann AF; Hagey LR
    Cell Mol Life Sci; 2008 Aug; 65(16):2461-83. PubMed ID: 18488143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the conjugation and formation of bile acids in the human liver.
    EKDAHL PH
    Acta Chir Scand Suppl; 1958; 115(Suppl 233):1-19. PubMed ID: 13594203
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting bile-acid signalling for metabolic diseases.
    Thomas C; Pellicciari R; Pruzanski M; Auwerx J; Schoonjans K
    Nat Rev Drug Discov; 2008 Aug; 7(8):678-93. PubMed ID: 18670431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and dynamic determinants of ligand binding in the ternary complex of chicken liver bile acid binding protein with two bile salts revealed by NMR.
    Eliseo T; Ragona L; Catalano M; Assfalg M; Paci M; Zetta L; Molinari H; Cicero DO
    Biochemistry; 2007 Nov; 46(44):12557-67. PubMed ID: 17929837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of the bile acid receptor TGR5 in Kupffer cells.
    Keitel V; Donner M; Winandy S; Kubitz R; Häussinger D
    Biochem Biophys Res Commun; 2008 Jul; 372(1):78-84. PubMed ID: 18468513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-based modeling and binding studies of a ternary complex between chicken liver bile acid binding protein and bile acids.
    Tomaselli S; Ragona L; Zetta L; Assfalg M; Ferranti P; Longhi R; Bonvin AM; Molinari H
    Proteins; 2007 Oct; 69(1):177-91. PubMed ID: 17607743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acids as Signal Integrators and Metabolic Modulators. Preface.
    Häussinger D
    Dig Dis; 2015; 33(3):299. PubMed ID: 26045260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stable isotopes in gastroenterology research and diagnosis].
    Paumgartner G; Stellaard F
    Z Gastroenterol Verh; 1985 Apr; 20():100-4. PubMed ID: 2409687
    [No Abstract]   [Full Text] [Related]  

  • 13. Why bile acid glucuronidation is a minor pathway for conjugation of endogenous bile acids in man.
    Hofmann AF
    Hepatology; 2007 Apr; 45(4):1083-4; author reply 1084-5. PubMed ID: 17393523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism of bile acids].
    LAMBIOTTE M; FALLOT P
    Rev Int Hepatol; 1957; 7(7):541-56. PubMed ID: 13506335
    [No Abstract]   [Full Text] [Related]  

  • 15. Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats.
    van Meer H; Boehm G; Stellaard F; Vriesema A; Knol J; Havinga R; Sauer PJ; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G540-7. PubMed ID: 18079281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
    Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
    Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
    Assfalg M; Gianolio E; Zanzoni S; Tomaselli S; Russo VL; Cabella C; Ragona L; Aime S; Molinari H
    J Med Chem; 2007 Nov; 50(22):5257-68. PubMed ID: 17915850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
    Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control.
    Kuipers F; Stroeve JH; Caron S; Staels B
    Curr Opin Lipidol; 2007 Jun; 18(3):289-97. PubMed ID: 17495603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.